Skip to main content
Premium Trial:

Request an Annual Quote

Applera Board Okays Applied Biosystems Stock Buyback

NEW YORK, Aug. 29 (GenomeWeb News) – Applied Biosystems said today that its repurchase of up to $200 million of its common stock has been approved by the board of directors of its parent firm, Applera.

Foster City, Calif.-based Applied Biosystems said that the authorization supplements its existing authority to replenish shares issued under its employee stock benefits plan. The authorization has no time restrictions, the company added, and calls for the stock buyback to be made at times and prices management deems appropriate through open market purchases, privately negotiated transactions, tender offers, exchange offers, or otherwise.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.